Related Experiment Video
Updated: Jul 1, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A
Faezeh Khodaie1, Abdorreza Naser Moghadasi1, Abolfazl Hosseinnataj2
1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Objective:
The time to diagnosis of multiple sclerosis (MS) is of great importance for early treatment, thereby reducing the disability and burden of the disease. The purpose of this study was to determine the time from the onset of clinical symptoms to the diagnosis of MS and to evaluate the factors associated with a late diagnosis in Iranian MS patients.
Methods:
The present cross-sectional study was conducted on patients with MS who were registered in the National MS Registry System of Iran (NMSRI).
Results:
Overall, 23291 MS patients registered in 18 provinces of Iran were included in this study. The mean (standard deviation) interval between the onset of the disease and diagnosis of MS was 13.42 (32.40) months, and the median was one month. The diagnostic interval of 41.6% of patients was less than one month, and 14.8% of them had a one-month time to diagnosis. Patients with an age of onset below 18 years and those diagnosed after the age of 50 years had a longer time to diagnosis (P<0.001). Patients with primary progressive MS (PPMS) had the longest time to diagnose and those with relapsing-remitting MS (RRMS) had the shortest time (P<0.001). The results of negative binominal regression showed that the average rate of delay in diagnosis in women was 12% less than that in men. The average delay in diagnosis in patients with a positive family history of MS was 23% more than that in others. The rate of delay in the diagnosis of patients with PPMS and secondary progressive MS was 2.22 and 1.66 times higher, respectively, compared with RRMS.
Conclusion:
The findings of the present study revealed that more than half of the MS patients were diagnosed within a one-month interval from the symptom onset, which is an acceptable period. More attention should be paid to patients' access to medical facilities and MS specialists.
Insights
Most multiple sclerosis (MS) patients in Iran receive a diagnosis within one month of symptom onset. Factors like age, MS type, and family history influence diagnosis delays.
Area of Science:
- Neurology
- Epidemiology
Background:
- Timely diagnosis of multiple sclerosis (MS) is crucial for effective treatment and reducing disease burden.
- Understanding factors influencing diagnosis delays can improve patient outcomes.
Purpose of the Study:
- To determine the time from symptom onset to diagnosis in Iranian multiple sclerosis patients.
- To identify factors associated with delayed diagnosis.
Main Methods:
- A cross-sectional study utilizing data from the National MS Registry System of Iran (NMSRI).
- Inclusion of 23,291 MS patients across 18 provinces.
- Analysis of demographic and clinical factors impacting diagnosis time.
Main Results:
- The median time to diagnosis was one month, with 41.6% diagnosed in under a month.
- Younger (<18) and older (>=50) age at onset, primary progressive MS (PPMS), and secondary progressive MS (SPMS) were associated with longer diagnosis times.
- Women experienced shorter delays than men; a positive family history correlated with longer delays.
Conclusions:
- Over half of Iranian MS patients are diagnosed within an acceptable one-month timeframe.
- Improving access to medical facilities and MS specialists is essential for further reducing diagnosis delays.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Schizophrenia

